MedPath

Microcrystalline cellulose

Generic Name
Microcrystalline cellulose
Drug Type
Small Molecule
CAS Number
9004-34-6
Unique Ingredient Identifier
BX81F82EWG
Background

A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations.

Indication

用于体表创伤、外科创面止血及上消化道出血。

Associated Conditions
Vaginal burning sensation, Vaginal itching

Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty

Not Applicable
Completed
Conditions
Pseudoexfoliation Glaucoma
Primary Open Angle Glaucoma
Interventions
First Posted Date
2007-06-12
Last Posted Date
2015-09-23
Lead Sponsor
Queen's University
Target Recruit Count
120
Registration Number
NCT00485108
Locations
🇨🇦

Queen's University, Kingston, Ontario, Canada

Contraceptive Effectiveness Trial of Cellulose Sulfate Gel

Phase 2
Completed
Conditions
Contraception
First Posted Date
2005-11-18
Last Posted Date
2005-11-18
Lead Sponsor
CONRAD
Target Recruit Count
200
Registration Number
NCT00255294
Locations
🇺🇸

California Family Health Council, Los Angeles, California, United States

Cellulose Sulfate and HIV Transmission Among Women

Phase 3
Terminated
Conditions
HIV Infection
First Posted Date
2005-09-12
Last Posted Date
2015-08-28
Lead Sponsor
CONRAD
Target Recruit Count
1428
Registration Number
NCT00153777
Locations
🇺🇬

Makarere University - Mulago Hospital, Kampala, Uganda

🇧🇯

Projet SIDA3, Cotonou, Benin

🇮🇳

Karnataka Health Promotion Trust, Bangalore, India

and more 2 locations

Is Myopathy Part of Statin Therapy (IMPOSTER-16)

Phase 4
Withdrawn
Conditions
Myopathic Conditions
Interventions
First Posted Date
2005-08-05
Last Posted Date
2022-11-23
Lead Sponsor
Scripps Health
Registration Number
NCT00127335
Locations
🇺🇸

Scripps Mercy Hospital, San Diego, California, United States

Cellulose Sulfate (CS) Gel and HIV in Nigeria

Phase 3
Terminated
Conditions
Chlamydia Infections
HIV Infections
Gonorrhea
First Posted Date
2005-07-19
Last Posted Date
2007-02-28
Lead Sponsor
FHI 360
Target Recruit Count
2160
Registration Number
NCT00120770
Locations
🇳🇬

University of Port Harcourt Teaching Hospital, Center 10152, Port Harcourt, Nigeria

🇳🇬

Lagos University, College of Medicine, Center 10151, Lagos, Nigeria

© Copyright 2025. All Rights Reserved by MedPath